In mid-December, E.I Du Pont De Nemours (NYSE:DD) announced its 2011 earnings per share would likely be a dime lower than its earlier forecast of $3.97 to $4.05. Even if earnings come in at the low-end of the range around $3.87 a share, there's still plenty to like about the global chemical company. Here are three reasons its future is bright.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

2012 Forecast

Despite cutting its 2011 earnings slightly last month, DuPont still expects a strong 2012 with revenues of at least $40 billion and earnings per share of $4.37. Leading the way will be its agriculture and nutrition products, as well as growth in the emerging markets of Asia and Latin America. In addition, its U.S. business is performing far better than anticipated. The two major concerns being Europe and its performance coatings unit, which sells paint to car manufacturers.

Rumor has it several private equity firms, including KKR (NYSE:KKR) and Onex (TSE:C.OCX), might be willing to pay as much as $4 billion for the struggling business. While Ellen Kullman, DuPont's CEO, denies any interest in selling, that would enable it to focus on its more profitable business segments. At a Jan. 3 closing price of $46.51, it's trading at less than 11 times earnings. This compares favorably to both The Dow Chemical (NYSE:DOW) and BASF (OTCBB:BASFY).

Agriculture and Food

In the most recent edition of Rotman, the University of Toronto's business school magazine, Kullman discusses the future of DuPont. One of only 12 female CEOs running a Fortune 500 company, the Delaware native took the reins in 2009 and immediately went to work focusing DuPont on the megatrends that will affect this planet for generations to come. Kullman pushed it into agriculture, nutrition, health, biotechnology and renewable energy. None of these were truly on its radar prior to her arrival and now represent the future of the company. A big step forward came in Jan. 2011 when it acquired Danisco, a Danish ingredient and enzyme company, for $6.3 billion. The acquisition was its second-largest in recent memory, creating two new reportable segments: Industrial Biosciences and Nutrition & Health. In the first nine months of 2011, those two segments delivered $2.07 billion in revenue, 130% higher than in the same period a year earlier. While generating very little pretax operating income at the moment, it's expected that this segment will deliver long-term revenue growth of at least 7% and net margins of 12%. With estimated 2011 revenues of $2.5 billion, we're talking about net income of $300 million. (To know more about acquisitions, read Analyzing An Acquisition Announcement.)

Emerging Markets

Revenues for the first nine months of 2011 in emerging markets were tremendous. The biggest gain came from Latin America, which experienced a sales increase of 35% to $3.5 billion, followed by the Asia Pacific region at 28% and EMEA (Europe, Middle East and Africa) at 24%. All four geographic regions represent at least 10% of overall revenues. Asia can expect most of the world's population growth in the next 40 years and therefore will need 70% more food production and additional energy to meet this growth. Not only will its agriculture business and assist in the growth, but so too will its electronics, automotive and packaging businesses. The revenues in Asia Pacific are about 58% of those in Canada and the U.S. Given current growth rates, they could exceed them by the end of the decade.

The Bottom Line

If you need a large cap stock to fill a gap in your portfolio, you could do a lot worse than DuPont. Especially now that it's changed course in search of growth. It's how a 210-year-old business stays in business. (For additional reading, check out 5 Must-Have Metrics For Value Investors.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!
At the time of writing, Will Ashworth did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  2. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  3. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  4. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  5. Stock Analysis

    Tech Stocks Vs. Financial Stocks in 2016

    Consider the arguments for allocating more of your investment portfolio to either the technology sector or the financial sector for 2016.
  6. Stock Analysis

    The Top 5 Financial Penny Stocks for 2016 (CPSS, ASRV)

    Learn about some of the most promising penny stocks in the financial services sector that investors can consider adding to their portfolio for 2016.
  7. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  8. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  9. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
  10. Investing News

    A 2016 Outlook: What January 2009 Can Teach Us

    January 2009 and January 2016 were similar from an investment standpoint, but from a forward-looking perspective, they were very different.
  1. How can insurance companies find out about DUIs and DWIs?

    An insurance company can find out about driving under the influence (DUI) or driving while intoxicated (DWI) charges against ... Read Full Answer >>
  2. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  3. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  4. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  5. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  6. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
Trading Center